Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00767234 · ClinicalTrials.gov registry record
Permission to Collect Blood Over Time for Research
A clinical trial, sponsored by Stanford University.
- Terminated
- Registry status
- 104
- Enrollment target
NCT00767234: Clinical Trial study, sponsored by Stanford University.
NCT00767234 is a clinical trial that was terminated before completion, run by Stanford University. The registered enrollment target is 104 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00767234 was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- 104 participants
- Enrollment target
Study Summary
To determine whether biomarkers assessed in blood samples can be used to detect individuals at risk for developing blood clots or worsening of their underlying disease. The ultimate goal of the study is to identify key biomarkers derived from blood that are most characteristic and informative of individuals who will go on to develop a clotting complication.
Interventions
- PROCEDURE Observation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2008-08 |
| Est. Completion | 2011-10 |
Why NCT00767234 stopped before completion
NCT00767234 is an observational study that tracks outcomes without assigning an intervention. The registered 104 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Observation is the first listed.
NCT00767234 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00767234 about?
NCT00767234 is a clinical study titled "Permission to Collect Blood Over Time for Research". To determine whether biomarkers assessed in blood samples can be used to detect individuals at risk for developing blood clots or worsening of their underlying disease. The ultimate goal of the study is to identify key biomarkers derived from blood that are most characteristic and informative of ind...
What is the current status of trial NCT00767234?
This trial is currently terminated. The enrollment target is 104 participants. The study started on 2008-08. Estimated completion is 2011-10.
What interventions are being tested in trial NCT00767234?
The interventions under investigation include: Observation (PROCEDURE).
Who is sponsoring clinical trial NCT00767234?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03403686 · 104 participants
Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)
- NCT04228367 · 104 participants · NA
JuggerStitch Post Market Clinical Follow-up Study
- NCT04268849 · 104 participants · Phase 3
Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient
- NCT04390724 · 104 participants
Optimizing Y90 Therapy for Radiation Lobectomy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia